bioRxiv ScienceSearch

Biology subjects

Kalari, K.

Publications and source records attributed to Kalari, K..

2 recordsLinked to original sources

Gene Sets Analysis using Network Patterns

High throughput assays allow researchers to identify sets of genes related to experimental conditions or phenotypes of interest. These gene sets are frequently subjected to functional interpretation using databases of gene annotations. Recent approaches have extended this approach to also consider networks of gene-gene relationships and interactions when attempting to characterize properties of a gene set. We present here a supervised learning algorithm for gene set analysis, called GeneSet MAPR, that for the first time explicitly considers the patterns of direct as well as indirect relationships present in the network to quantify gene-gene similarities and then report shared properties of the gene set. Our extensive evaluations show that GeneSet MAPR performs better than other network-based methods for the task of identifying genes related to a given gene set, enabling more reliable functional characterizations of the gene set. When applied to the set of response-associated genes from a triple negative breast cancer study, GeneSet MAPR uncovers gene families such as claudins, kallikreins, and collagen type alpha chains related to patients response to treatment, and which are not uncovered with traditional analysis.

systems biology

MIR2052HG regulates ERα levels and aromatase inhibitor resistance through LMTK3 by recruiting EGR1

Our previous GWAS using the MA.27 aromatase inhibitors (AIs) adjuvant trial identified SNPs in the lncRNA MIR2052HG associated with breast cancer free interval. Here we report that MIR2052HG depletion in breast cancer cells results in a decrease in LMTK3 expression and cell growth. Mechanistically, MIR2052HG interacts with EGR1 and facilitates its recruitment to the LMTK3 promoter. LMTK3 sustains ER levels by reducing PKC activity, resulting in increased ESR1 transcription mediated through AKT/FOXO3 and reduced ER degradation mediated by the PKC/MEK/ERK/RSK1 pathway. MIR2052HG regulated LMTK3 in a SNP- and aromatase inhibitor - dependent fashion: the variant SNP increased EGR1 binding to LMTK3 promoter in response to androstenedione, relative to wild-type genotype, a pattern that can be reversed by aromatase inhibitor treatment. Finally, LMTK3 overexpression abolished the effect of MIR2052HG on PKC activity and ER levels. These results reveal a direct role of MIR2052HG in LMTK3 regulation and raise the possibility of targeting MIR2052HG or LMTK3 in ER-positive breast cancer.

cancer biology